人工智能在肿瘤委员会中的作用：外科医生、肿瘤内科医生和肿瘤放射科医生的观点

IF 2.8 4区医学 Q2 ONCOLOGY

Current oncology Pub Date : 2024-08-27 DOI:10.3390/curroncol31090369

Valerio Nardone, Federica Marmorino, Marco Maria Germani, Natalia Cichowska-Cwalińska, Vittorio Salvatore Menditti, Paolo Gallo, Vittorio Studiale, Ada Taravella, Matteo Landi, Alfonso Reginelli, Salvatore Cappabianca, Sergii Girnyi, Tomasz Cwalinski, Virginia Boccardi, Aman Goyal, Jaroslaw Skokowski, Rodolfo J. Oviedo, Adel Abou-Mrad, Luigi Marano

{"title":"人工智能在肿瘤委员会中的作用：外科医生、肿瘤内科医生和肿瘤放射科医生的观点","authors":"Valerio Nardone, Federica Marmorino, Marco Maria Germani, Natalia Cichowska-Cwalińska, Vittorio Salvatore Menditti, Paolo Gallo, Vittorio Studiale, Ada Taravella, Matteo Landi, Alfonso Reginelli, Salvatore Cappabianca, Sergii Girnyi, Tomasz Cwalinski, Virginia Boccardi, Aman Goyal, Jaroslaw Skokowski, Rodolfo J. Oviedo, Adel Abou-Mrad, Luigi Marano","doi":"10.3390/curroncol31090369","DOIUrl":null,"url":null,"abstract":"The integration of multidisciplinary tumor boards (MTBs) is fundamental in delivering state-of-the-art cancer treatment, facilitating collaborative diagnosis and management by a diverse team of specialists. Despite the clear benefits in personalized patient care and improved outcomes, the increasing burden on MTBs due to rising cancer incidence and financial constraints necessitates innovative solutions. The advent of artificial intelligence (AI) in the medical field offers a promising avenue to support clinical decision-making. This review explores the perspectives of clinicians dedicated to the care of cancer patients—surgeons, medical oncologists, and radiation oncologists—on the application of AI within MTBs. Additionally, it examines the role of AI across various clinical specialties involved in cancer diagnosis and treatment. By analyzing both the potential and the challenges, this study underscores how AI can enhance multidisciplinary discussions and optimize treatment plans. The findings highlight the transformative role that AI may play in refining oncology care and sustaining the efficacy of MTBs amidst growing clinical demands.","PeriodicalId":11012,"journal":{"name":"Current oncology","volume":null,"pages":null},"PeriodicalIF":2.8000,"publicationDate":"2024-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The Role of Artificial Intelligence on Tumor Boards: Perspectives from Surgeons, Medical Oncologists and Radiation Oncologists\",\"authors\":\"Valerio Nardone, Federica Marmorino, Marco Maria Germani, Natalia Cichowska-Cwalińska, Vittorio Salvatore Menditti, Paolo Gallo, Vittorio Studiale, Ada Taravella, Matteo Landi, Alfonso Reginelli, Salvatore Cappabianca, Sergii Girnyi, Tomasz Cwalinski, Virginia Boccardi, Aman Goyal, Jaroslaw Skokowski, Rodolfo J. Oviedo, Adel Abou-Mrad, Luigi Marano\",\"doi\":\"10.3390/curroncol31090369\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The integration of multidisciplinary tumor boards (MTBs) is fundamental in delivering state-of-the-art cancer treatment, facilitating collaborative diagnosis and management by a diverse team of specialists. Despite the clear benefits in personalized patient care and improved outcomes, the increasing burden on MTBs due to rising cancer incidence and financial constraints necessitates innovative solutions. The advent of artificial intelligence (AI) in the medical field offers a promising avenue to support clinical decision-making. This review explores the perspectives of clinicians dedicated to the care of cancer patients—surgeons, medical oncologists, and radiation oncologists—on the application of AI within MTBs. Additionally, it examines the role of AI across various clinical specialties involved in cancer diagnosis and treatment. By analyzing both the potential and the challenges, this study underscores how AI can enhance multidisciplinary discussions and optimize treatment plans. The findings highlight the transformative role that AI may play in refining oncology care and sustaining the efficacy of MTBs amidst growing clinical demands.\",\"PeriodicalId\":11012,\"journal\":{\"name\":\"Current oncology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":2.8000,\"publicationDate\":\"2024-08-27\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Current oncology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3390/curroncol31090369\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3390/curroncol31090369","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}

引用次数: 0

摘要

多学科肿瘤委员会（MTBs）的整合是提供最先进癌症治疗的基础，有利于不同专家团队的合作诊断和管理。尽管在个性化患者护理和改善疗效方面有明显优势，但由于癌症发病率上升和财政限制，多学科肿瘤委员会的负担日益加重，因此需要创新的解决方案。人工智能（AI）在医疗领域的出现为支持临床决策提供了一条大有可为的途径。本综述探讨了致力于癌症患者护理的临床医生--外科医生、肿瘤内科医生和肿瘤放射科医生--对人工智能在 MTB 中应用的看法。此外，它还研究了人工智能在癌症诊断和治疗的各临床专科中的作用。通过分析潜力和挑战，本研究强调了人工智能如何加强多学科讨论和优化治疗计划。研究结果强调了人工智能在完善肿瘤治疗和在临床需求不断增长的情况下维持 MTB 的疗效方面可能发挥的变革性作用。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

The Role of Artificial Intelligence on Tumor Boards: Perspectives from Surgeons, Medical Oncologists and Radiation Oncologists

The integration of multidisciplinary tumor boards (MTBs) is fundamental in delivering state-of-the-art cancer treatment, facilitating collaborative diagnosis and management by a diverse team of specialists. Despite the clear benefits in personalized patient care and improved outcomes, the increasing burden on MTBs due to rising cancer incidence and financial constraints necessitates innovative solutions. The advent of artificial intelligence (AI) in the medical field offers a promising avenue to support clinical decision-making. This review explores the perspectives of clinicians dedicated to the care of cancer patients—surgeons, medical oncologists, and radiation oncologists—on the application of AI within MTBs. Additionally, it examines the role of AI across various clinical specialties involved in cancer diagnosis and treatment. By analyzing both the potential and the challenges, this study underscores how AI can enhance multidisciplinary discussions and optimize treatment plans. The findings highlight the transformative role that AI may play in refining oncology care and sustaining the efficacy of MTBs amidst growing clinical demands.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Current oncology ONCOLOGY-

CiteScore

3.30

自引率

7.70%

发文量

664

审稿时长

1 months

期刊介绍： Current Oncology is a peer-reviewed, Canadian-based and internationally respected journal. Current Oncology represents a multidisciplinary medium encompassing health care workers in the field of cancer therapy in Canada to report upon and to review progress in the management of this disease. We encourage submissions from all fields of cancer medicine, including radiation oncology, surgical oncology, medical oncology, pediatric oncology, pathology, and cancer rehabilitation and survivorship. Articles published in the journal typically contain information that is relevant directly to clinical oncology practice, and have clear potential for application to the current or future practice of cancer medicine.